MENU
+Compare
MIST
Stock ticker: NASDAQ
AS OF
Jul 25, 04:59 PM (EDT)
Price
$1.57
Change
+$0.01 (+0.64%)
Capitalization
134.24M

MIST Milestone Pharmaceuticals Forecast, Technical & Fundamental Analysis

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MIST with price predictions
Jul 25, 2025

MIST's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for MIST moved out of overbought territory on July 11, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MIST turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

MIST moved below its 50-day moving average on July 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIST crossed bearishly below the 50-day moving average on July 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MIST broke above its upper Bollinger Band on July 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where MIST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on MIST as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 127 cases where MIST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.960) is normal, around the industry mean (18.053). P/E Ratio (0.000) is within average values for comparable stocks, (59.920). MIST's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.580). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (74.074) is also within normal values, averaging (280.104).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MIST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIST is expected to report earnings to fall 41.94% to -18 cents per share on August 06

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q2'25
Est.
$-0.18
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.05
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 488.29K shares outstanding, the current market capitalization sits at 134.24M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMMS2.55N/A
N/A
Emmis Corporation
CJEWF1.59N/A
N/A
Chow Tai Fook Jewellery Group Limited
JPDYY1.18N/A
N/A
Japan Display, Inc.
JSGCF12.00N/A
N/A
LIXIL Corp.
ZDZT1.92N/A
N/A
Zhengduozhe Technology Inc

MIST and Stocks

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-1.87%
AKBA - MIST
33%
Poorly correlated
-0.26%
GYRE - MIST
29%
Poorly correlated
+2.07%
ETNB - MIST
29%
Poorly correlated
-0.99%
PRAX - MIST
29%
Poorly correlated
+1.60%
OSRH - MIST
29%
Poorly correlated
-5.88%
More